You're Using Drops Daily, Yet Your Eyes Stay Dry. Here's Why.

The VDR gene encodes the vitamin D receptor, a protein that sits on immune cells and epithelial cells throughout your body, including your eyes. When vitamin D binds to VDR, it turns on genes that suppress excessive inflammation and promote immune tolerance. Your eyes depend on this signaling to keep the ocular surface calm and protected.

VDR variants reduce the receptor’s sensitivity to vitamin D, meaning your immune cells stay more activated and your ocular surface remains inflamed even with adequate vitamin D intake. People carrying certain VDR polymorphisms have been shown to have higher rates of dry eye disease, especially when vitamin D levels are on the lower side of normal. If your VDR is inefficient, standard vitamin D supplementation may not be enough to calm your eye inflammation.

You might notice that your eyes flare up in winter when sun exposure is low, or that moving to a sunnier climate doesn’t help as much as you’d expect. You may also have experienced other signs of reduced immune tolerance: frequent sinus infections, seasonal allergies that hit harder than others around you, or a general sense that your body overreacts to minor triggers.

MTHFR is the enzyme responsible for converting dietary folate into its active form, methylfolate. This isn’t just about energy or one-carbon metabolism. Methylfolate is a critical cofactor for nitric oxide synthase, the enzyme that produces nitric oxide in blood vessel walls. Without adequate nitric oxide production, your ocular blood vessels can’t dilate properly, and blood flow to the lacrimal glands and ocular surface becomes compromised.

The MTHFR C677T variant, carried by approximately 40% of European ancestry populations, reduces enzyme activity by 40 to 70%. People with this variant often have elevated homocysteine and reduced nitric oxide production, leading to poor ocular perfusion and a vicious cycle of inflammation and ischemia at the eye surface. This is especially true if you’re not consuming adequate B vitamins or if your methylation status is already strained by stress, poor sleep, or other genetic variants.

You may have noticed that your dry eyes come with a general sense of fatigue, brain fog, or even mild circulation issues in your hands and feet. You might bruise easily, recover slowly from exercise, or feel that your eyes get worse under stress when your methylation demand is highest.

TNF-alpha is one of the body’s most potent inflammatory signaling molecules. It’s released by immune cells in response to infection, injury, or perceived threats. In the eye, TNF-alpha activates ocular surface inflammation, triggers goblet cell dysfunction, and promotes epithelial cell death. A little TNF is necessary for immune defense. Too much TNF becomes the driver of chronic, stubborn inflammation that no drop can reverse.

The TNF -308G>A variant, carried by roughly 30% of European ancestry populations, is associated with higher TNF-alpha production. People with the A allele tend to produce significantly more TNF-alpha under baseline conditions, creating a chronically inflamed ocular surface even at rest. This variant is particularly problematic in dry eye because it amplifies the inflammatory cascade while simultaneously impairing the production of tear components that protect the surface.

You might notice that your eyes are almost always red and irritated, that the discomfort seems almost independent of environmental triggers (you don’t need dry air or screens to feel the burn), and that your eyes seem to worsen with even minor stress or illness. You may also have a history of other inflammatory conditions: joint stiffness, digestive issues, or general low-grade systemic inflammation.

IL-6 is an inflammatory cytokine that amplifies the immune response and extends the duration of inflammation. Unlike TNF, which acts quickly and then stops, IL-6 maintains a low-level inflammatory hum that can persist for days or weeks. In the eye, IL-6 impairs tear secretion, damages mucin-producing goblet cells, and promotes a vicious cycle where inflammation begets more inflammation.

The IL6 -174G>C variant, present in roughly 40% of populations, is associated with higher baseline IL-6 production. People carrying the C allele tend to maintain elevated IL-6 levels at rest and produce exaggerated IL-6 responses to any immune trigger, meaning their eyes stay inflamed longer after any irritation or infection. This creates a situation where your eye feels continuously bothered, even days after something minor happens.

You might experience dry eyes that get worse over the course of the day, that never fully resolve even after a full night of sleep, or that intensify after exposure to any trigger (dust, pollen, smoke). You may also notice that once your eyes flare up, it takes forever for them to calm down again, and that brief periods of relief are followed by re-inflammation.

SOD2 is the mitochondrial form of superoxide dismutase, an enzyme that neutralizes superoxide radicals produced by mitochondria. Mitochondria power every cell, but they also leak free radicals as a byproduct of energy production. Your ocular surface cells are particularly vulnerable to oxidative damage because photoreceptors and retinal cells generate enormous amounts of oxidative stress from light exposure. Without robust SOD2 function, oxidative damage accumulates, triggering inflammation and cell death.

The SOD2 Val16Ala variant, found in roughly 40% of populations, reduces the enzyme’s activity and leads to increased mitochondrial oxidative stress. People carrying the Ala variant have lower antioxidant capacity in their cells, which means oxidative stress accumulates more quickly in response to light, heat, and metabolic demand, directly damaging the ocular surface. This is especially problematic because oxidative stress both triggers inflammation and impairs your immune system’s ability to resolve it.

You might notice that your dry eyes worsen in bright light, that they feel especially bad after spending time in the sun or in front of screens, and that they seem to decline over months and years in a way that suggests cumulative damage. You may also feel that your eyes are unusually sensitive to environmental stressors.

COMT breaks down dopamine, adrenaline, and noradrenaline. These aren’t just neurotransmitters. They’re also powerful signaling molecules that regulate immune tolerance, inflammation resolution, and stress response. Dopamine, in particular, has potent anti-inflammatory effects and promotes the production of regulatory T cells that calm excessive immune activation. When COMT is overactive, dopamine gets cleared too quickly, and the eye loses this anti-inflammatory protection.

The COMT Val158Met variant (homozygous for Val, roughly 25% of European ancestry populations) produces an enzyme that’s three to fourfold more active than the Met variant. Fast COMT metabolizers clear dopamine and adrenaline rapidly, leaving them chronically depleted in these signaling molecules and more vulnerable to sustained inflammation and poor stress resilience. This means your immune system struggles to resolve inflammation once it starts, and your ocular surface pays the price.

You might notice that your dry eyes worsen under stress, that you’re generally more caffeine-sensitive or that caffeine makes your anxiety or racing thoughts worse, and that you tend to be a worrier or high-strung. You may also find that your eyes flare up when you’re emotionally overwhelmed or mentally fatigued.